S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ATNF 180 Life Sciences Corporation

1.95

-0.09 (-4.41%)

11 May 2024 - Closed

Delayed by 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

180 Life Sciences (NASDAQ:ATNF)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more 180 Life Sciences Charts.

180 Life Sciences (NASDAQ:ATNF)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more 180 Life Sciences Charts.

180 Life Sciences Corporation News

180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 9 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 28 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 26 February 2024 (2 months ago) • Edgar (US Regulatory)

180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
Monday 26 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 21 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Saturday 17 February 2024 (3 months ago) • Edgar (US Regulatory)

More 180 Life Sciences Corporation News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions